PLUS1
15.93
0.00 (0.0%)
0.00 (0.0%)
Upgrade to Real-Time
Premarket
Low
11.22
High
29.6473
Best deals to access real time data! |
|
Ultimate Trader (Monthly)
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Big Cap Pro
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Cara Therapeutics Inc | CARA | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| 0.00 | 0.0% | 15.93 | 07:09:11 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 15.93 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 15.85 | 16.39 | 0.54 | - | - |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 5 | 235 | - | 11.22 - 29.6473 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 07:05:41 | 15 | $ 15.54 | USD |
Period:
Draw Mode:
Cara Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 797.93M | 50.09M | 49.12M | $ 135.08M | $ 9.16M | 0.18 | 60.10 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | 138.54k | 3.50% |
Cara Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CARA Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 14.84 | 16.1303 | 14.81 | 15.63 | 548,470 | 1.09 | 7.35% |
| 1 Month | 14.18 | 16.28 | 14.151 | 15.39 | 914,140 | 1.75 | 12.34% |
| 3 Months | 14.49 | 18.25 | 11.22 | 14.40 | 1,607,451 | 1.44 | 9.94% |
| 6 Months | 20.04 | 29.6473 | 11.22 | 16.74 | 1,445,665 | -4.11 | -20.51% |
| 1 Year | 12.98 | 29.6473 | 11.22 | 16.76 | 951,588 | 2.95 | 22.73% |
| 3 Years | 23.13 | 29.6473 | 8.88 | 17.61 | 721,378 | -7.20 | -31.13% |
| 5 Years | 7.86 | 29.6473 | 5.85 | 16.21 | 996,963 | 8.07 | 102.67% |
Cara Therapeutics Description
| Cara Therapeutics Inc is an emerging biotechnology company involved in the development of novel therapeutics to treat human diseases associated with inflammation, pain, and pruritus. Cara's most advanced compound, CR845, aims to treat acute pain and pruritus. This patented compound has analgesic, anti-inflammatory, and antipruritic properties that can be used for multiple therapeutic applications. Additionally, Cara's objective is to use its proprietary drug-screening technology to develop a future pipeline of first-in-class molecules with analgesic and anti-inflammatory features. |
